MACROGENICS INC — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Karrels James | SVP, CFO and Secretary | Option Exercise | 5,000 | $0.94 | $4,700 | 105,331 | Jan 25, 2017 |
| Koenig Scott | President and CEO | Option Exercise | 79,898 | $0.94 | $75,104 | 133,163 | Jan 17, 2017 |
| Bonvini Ezio | Sr VP, Research & CSO | Option Exercise | 11,962 | $0.94 | $11,244 | 95,595 | Oct 19, 2016 |
| Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | Sale | 10,000 | $29.34 | $293,400 | — | Oct 3, 2016 |
| Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | Sale | 10,000 | $29.34 | $293,400 | — | Oct 3, 2016 |
| Cilinski Lynn | VP, Controller and Treasurer | Option Exercise | 6,231 | $0.94 | $5,857 | 8,154 | Oct 3, 2016 |
| Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | Sale | 10,000 | $29.34 | $293,400 | 30,000 | Oct 3, 2016 |
| Wigginton Jon Marc | Sr VP Clinical Dev & CMO | Sale | 20,000 | $30.78 | $615,600 | — | Aug 1, 2016 |
| Cilinski Lynn | VP, Controller and Treasurer | Sale | 8,922 | $27.22 | $242,857 | 1,923 | Jul 1, 2016 |
| Wigginton Jon Marc | Sr VP Clinical Dev & CMO | Option Exercise | 5,000 | $4.70 | $23,500 | 5,000 | Jul 1, 2016 |
| Cilinski Lynn | VP, Controller and Treasurer | Option Exercise | 5,000 | $0.94 | $4,700 | 6,923 | May 27, 2016 |
| Koenig Scott | President and CEO | Other | 79,898 | — | — | 167,782 | May 18, 2016 |
| Koenig Scott | President and CEO | Option Exercise | 34,619 | $0.94 | $32,542 | 167,782 | May 16, 2016 |
| Koenig Scott | President and CEO | Option Exercise | 79,898 | $0.94 | $75,104 | 133,163 | May 11, 2016 |
| SARAN ATUL | SVP & General Counsel | Tax Withholding | 1,730 | $20.84 | $36,053 | 18,980 | Apr 28, 2016 |
| SARAN ATUL | SVP & General Counsel | Tax Withholding | 1,862 | $20.84 | $38,804 | 18,848 | Apr 28, 2016 |
| Costa Paulo F | — | Purchase | 10,000 | $17.20 | $172,000 | 59,435 | Mar 3, 2016 |
| Wigginton Jon Marc | Sr VP, Clinical Dev & CMO | Award / Grant | 30,000 | — | — | 30,000 | Feb 25, 2016 |
| Risser Eric Blasius | SVP, Business Development | Option Exercise | 2,500 | $0.94 | $2,350 | 4,000 | Feb 8, 2016 |
| Karrels James | SVP, CFO and Secretary | Option Exercise | 10,000 | $0.94 | $9,400 | 100,331 | Jan 29, 2016 |
| Bonvini Ezio | Senior VP, Research | Option Exercise | 4,421 | $0.94 | $4,156 | 74,738 | Jan 7, 2016 |
| Stein Kathryn E | SVP, Product Dev. & Regulatory | Option Exercise | 4,421 | $0.94 | $4,156 | 63,179 | Jan 7, 2016 |
| Wigginton Jon Marc | Sr VP, Clinical | Sale | 10,000 | $29.64 | $296,400 | — | Jan 4, 2016 |
| Risser Eric Blasius | SVP, Business Development | Option Exercise | 1,500 | $0.94 | $1,410 | 1,500 | Dec 23, 2015 |
| Cilinski Lynn | VP, Controller and Treasurer | Option Exercise | 3,815 | $0.94 | $3,586 | 7,659 | Nov 23, 2015 |
| Bonvini Ezio | Senior VP, Research | Sale | 3,117 | $31.44 | $97,998 | 70,317 | Nov 16, 2015 |
| Bonvini Ezio | Senior VP, Research | Sale | 6,233 | $25.21 | $157,134 | 73,434 | Oct 15, 2015 |
| Bonvini Ezio | Senior VP, Research | Option Exercise | 14,521 | $0.71 | $10,310 | 94,188 | Oct 13, 2015 |
| Karrels James | SVP, CFO and Secretary | Option Exercise | 6,000 | $0.94 | $5,640 | 10,100 | Oct 7, 2015 |
| Bonvini Ezio | Senior VP, Research | Option Exercise | 5,893 | $0.94 | $5,539 | 79,667 | Oct 2, 2015 |
| Wigginton Jon Marc | Sr VP, Clinical | Sale | 5,000 | $21.11 | $105,550 | — | Oct 1, 2015 |
| Wigginton Jon Marc | Sr VP, Clinical | Option Exercise | 5,000 | $4.70 | $23,500 | 5,000 | Oct 1, 2015 |
| Bonvini Ezio | Senior VP, Research | Gift | 7,550 | — | — | 76,083 | Sep 22, 2015 |
| Bonvini Ezio | Sr VP, Research & CSO | Option Exercise | 5,349 | $0.94 | $5,028 | 93,394 | Sep 22, 2015 |
| Bonvini Ezio | Senior VP, Research | Option Exercise | 7,000 | $0.94 | $6,580 | 61,790 | Sep 18, 2015 |
| Bonvini Ezio | Senior VP, Research | Option Exercise | 4,000 | $0.94 | $3,760 | 54,790 | Sep 16, 2015 |
| Bonvini Ezio | Senior VP, Research | Option Exercise | 5,000 | $0.94 | $4,700 | 50,790 | Aug 26, 2015 |
| Bonvini Ezio | Senior VP, Research | Option Exercise | 4,000 | $0.94 | $3,760 | 40,790 | Aug 10, 2015 |
| Wigginton Jon Marc | Sr VP, Clinical | Option Exercise | 10,000 | $4.70 | $47,000 | 10,000 | Aug 3, 2015 |
| Wigginton Jon Marc | Sr VP, Clinical | Sale | 10,000 | $37.15 | $371,500 | — | Aug 3, 2015 |
| Bonvini Ezio | Senior VP, Research | Sale | 2,400 | $38.09 | $91,416 | 36,790 | Jul 10, 2015 |
| Wigginton Jon Marc | Sr VP, Clinical | Option Exercise | 5,000 | $4.70 | $23,500 | 5,000 | Jul 1, 2015 |
| Cilinski Lynn | VP, Controller and Treasurer | Option Exercise | 5,000 | $0.94 | $4,700 | 10,765 | Jul 1, 2015 |
| Bonvini Ezio | Senior VP, Research | Sale | 6,497 | $38.07 | $247,341 | 36,790 | Jun 30, 2015 |
| Bonvini Ezio | Senior VP, Research | Sale | 6,097 | $38.08 | $232,174 | 36,790 | Jun 24, 2015 |
| Bonvini Ezio | Senior VP, Research | Sale | 6,097 | $38.08 | $232,174 | 17,639 | Jun 24, 2015 |
| Bonvini Ezio | Senior VP, Research | Option Exercise | 13,054 | $0.71 | $9,268 | 49,844 | Jun 23, 2015 |
| Bonvini Ezio | Senior VP, Research | Sale | 13,054 | $38.14 | $497,880 | 23,736 | Jun 23, 2015 |
| Cilinski Lynn | VP, Controller and Treasurer | Option Exercise | 5,000 | $0.94 | $4,700 | 16,465 | Jun 15, 2015 |
| Bonvini Ezio | Senior VP, Research | Sale | 6,233 | $34.01 | $211,984 | 36,790 | Jun 15, 2015 |